BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
378 results:

  • 1. Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET.
    Xia S; Duan W; Xu M; Li M; Tang M; Wei S; Lin M; Li E; Liu W; Wang Q
    J Exp Clin Cancer Res; 2024 Apr; 43(1):103. PubMed ID: 38570866
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in Lung cancer through JNK/c-jun Signaling Pathway.
    Zhang Q; Hui M; Chen G; Huang H; Wang S; Ye Y; Wang Y; Wang M; Zhang S; Huang L; Zhang F; Liu Z
    J Agric Food Chem; 2024 Apr; 72(13):7244-7255. PubMed ID: 38517372
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
    Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
    Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RhoGDIβ inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
    Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
    Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
    Cui X; Huo D; Wang Q; Wang Y; Liu X; Zhao K; You Y; Zhang J; Kang C
    Cell Death Dis; 2024 Jan; 15(1):98. PubMed ID: 38286983
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CorrDiff: Corrective Diffusion Model for Accurate MRI brain Tumor Segmentation.
    Li W; Huang W; Zheng Y
    IEEE J Biomed Health Inform; 2024 Mar; 28(3):1587-1598. PubMed ID: 38215328
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung cancer.
    Levallet J; Biojout T; Bazille C; Douyère M; Dubois F; Ferreira DL; Taylor J; Teulier S; Toutain J; Elie N; Bernaudin M; Valable S; Bergot E; Levallet G
    Cell Death Dis; 2023 Dec; 14(12):823. PubMed ID: 38092743
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.
    Emmons MF; Bennett RL; Riva A; Gupta K; Carvalho LADC; Zhang C; Macaulay R; Dupéré-Richér D; Fang B; Seto E; Koomen JM; Li J; Chen YA; Forsyth PA; Licht JD; Smalley KSM
    Nat Commun; 2023 Nov; 14(1):7759. PubMed ID: 38030596
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FKBP38 Regulates Self-Renewal and Survival of GBM Neurospheres.
    Dowling AL; Walbridge S; Ertekin C; Namagiri S; Camacho K; Chowdhury A; Bryant JP; Kohut E; Heiss JD; Brown DA; Kumbar SG; Banasavadi-Siddegowda YK
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947640
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.
    Olloquequi J; Ettcheto M; Cano A; Fortuna A; Bicker J; Sánchez-Lopez E; Paz C; Ureña J; Verdaguer E; Auladell C; Camins A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762479
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Case Series of Soft Tissue Sarcoma Patients with brain Metastasis with Implications from Genomic and Transcriptomic Analysis.
    Park C; Kim R; Choi J; Kim M; Kim TM; Han I; Kim JI; Kim HS
    Cancer Res Treat; 2024 Apr; 56(2):665-674. PubMed ID: 37752792
    [TBL] [Abstract] [Full Text] [Related]  

  • 12.
    Gao X; Liu Y; Hong S; Yang H; Guan B; Ma X
    J Integr Neurosci; 2023 Aug; 22(5):135. PubMed ID: 37735118
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
    Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
    Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Differential functions of RhoGDIβ in malignant transformation and progression of urothelial cell following N-butyl-N-(4-hydmoxybutyl) nitrosamine exposure.
    Hua X; Zou R; Bai X; Yang Y; Lu J; Huang C
    BMC Biol; 2023 Aug; 21(1):181. PubMed ID: 37635218
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Propofol suppresses hormones levels more obviously than sevoflurane in pediatric patients with craniopharyngioma: A prospective randomized controlled clinical trial.
    Xiong J; Wang M; Gao J; Zhou Y; Pang Y; Sun Y
    PLoS One; 2023; 18(7):e0288863. PubMed ID: 37506116
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma.
    Santamarina-Ojeda P; Tejedor JR; Pérez RF; López V; Roberti A; Mangas C; Fernández AF; Fraga MF
    Mol Oncol; 2023 Sep; 17(9):1726-1743. PubMed ID: 37357610
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Differences in Transcriptomic Profiles of brain and Thyroid Tumors with NTRK Gene Rearrangement.
    Kechin AA; Koryukov MA; Smertina MA; Borobova VS; Oscorbin IP; Ivanov AA; Bakharev SY; Boyarskikh UA; Kushlinskii NE; Filipenko ML
    Bull Exp Biol Med; 2023 May; 175(1):78-85. PubMed ID: 37335445
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-jun and the pre-existing epigenetic modifications.
    Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
    Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Unwinding the modalities of necrosome activation and necroptosis machinery in neurological diseases.
    Gupta R; Kumari S; Tripathi R; Ambasta RK; Kumar P
    Ageing Res Rev; 2023 Apr; 86():101855. PubMed ID: 36681250
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease.
    Shuai W; Bu F; Zhu Y; Wu Y; Xiao H; Pan X; Zhang J; Sun Q; Wang G; Ouyang L
    J Med Chem; 2023 Jan; 66(2):1273-1300. PubMed ID: 36649216
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.